The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction
Open accessAbstract
BACKGROUND: The Y-box binding protein 1 (YB-1) possesses pleiotropic functions through its interactions with various cellular proteins, and its high expression levels make it a potential useful prognostic biomarker for cancer cells. Eukaryotic DNA topoisomerases, such as DNA topoisomerase 1 (TOPO1) and DNA topoisomerase 2 (TOPO2), are the essential DNA metabolism regulators that usually overexpressed in cancer cells, and multiple proteins have been reported to regulate the enzyme activity and the clinical efficacy of their inhibitors. The present study unraveled the interaction of YB-1 with TOPO1, and further investigated the related function and potential mechanisms during the interaction. METHODS: The direct association of TOPO1 with specific domain of YB-1 was explored by co-immunoprecipitation and GST pull-down assays. The interaction function was further clarified by DNA relaxation assays, co-immunoprecipitation and WST-8 assays with in vitro gain- and loss- of function models. RESULTS: We found that YB-1 interacts directly with TOPO1 (but not with TOPO2) and promotes TOPO1 catalytic activity. Interactions between YB-1 and TOPO1 increased when cancer cells were treated with the TOPO1 inhibitor, camptothecin (CPT), but not with the TOPO2 inhibitor, adriamycin (ADM). Furthermore, we found that the interaction is prevented by pretreatment with the antioxidant agent, N-acetyl cysteine, and that YB-1 downregulation renders cells resistant to CPT. CONCLUSIONS: Our findings suggest that nuclear YB-1 serves as an intracellular promoter of TOPO1 catalytic activity that enhances CPT sensitivity through its direct interaction with TOPO1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Identification of the TOPO1 binding domain in YB-1. A. Schematic illustration of the GST-YB-1 deletion mutants (Ise et al., 1999 [26]). CSD indicates the cold shock domain. Amino acid residues are numbered. B. Interaction of GST-YB-1 deletion mutants with ThioHis-TOPO1. Approximately 500 μg of each GST fusion protein was immobilized on 15 μl of glutathione-Sepharose 4B, and the resin was incubated with 500 μg of ThioHis-TOPO1. Resin bound proteins were examined by western blotting using anti-Thio (upper panel) or anti-GST (lower panel) antibodies. C. Interaction of GST-YB-1 deletion mutants with TOPO1 in nuclear lysis solutions of PC-3 cells. Approximately 500 μg of each GST fusion protein was immobilized on 15 μl of glutathione-Sepharose 4B, and the resin was incubated with 500 μg of PC-3 nuclear lysis. Resin bound proteins were western blotted and the membrane probed using TOPO1 (upper panel) or anti-GST (lower panel) antibodies.](https://figures.cochat.ai/paper-figures/28366358cccb4e628730f9b2133dc196/y-box-binding-protein-1-enhances-dna-topoisomerase-1-activity-and-sensitivity-to-figure-2.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Y-box binding protein 1 (YB-1), as a promoter of intracellular TOP-1 catalytic activity, can improve the sensitivity of irinotecan by directly interacting with TOP-1 [17].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
DNA topoisomerase II and its growing repertoire of biological functions
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2608 · Cited by 885
Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms
Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400944200 · Cited by 611
ROS, stress‐activated kinases and stress signaling in cancer
Benhar, M., Engelberg, D., & Levitzki, A. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf094 · Cited by 600
The pleiotropic functions of the Y‐box‐binding protein, YB‐1
Kohno, K., Izumi, H., Uchiumi, T., Ashizuka, M., & Kuwano, M. (2003) · BioEssays · doi:10.1002/bies.10300 · Cited by 502
Self-citationY-box-binding protein 1 (YB-1) and its functions
Eliseeva, I. A., Kim, E. R., Guryanov, S. G., Ovchinnikov, L. P., & Lyabin, D. N. (2011) · Biochemistry (Moscow) · doi:10.1134/s0006297911130049 · Cited by 389
Wolffe, A. P. (1994) · BioEssays · doi:10.1002/bies.950160407 · Cited by 381
Singh, A., Boldin-Adamsky, S., Thimmulappa, R. K., Rath, S. K., Ashush, H., Coulter, J., Blackford, A., Goodman, S. N., Bunz, F., Watson, W. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1401 · Cited by 367
Therapeutic strategies in epithelial ovarian cancer
Kim, A., Ueda, Y., Naka, T., & Enomoto, T. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-14 · Cited by 319
Cited by
Li, F., Jiang, T., Li, Q., & Ling, X. (2017) · PubMed · Cited by 315
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Sangermano, F., Delicato, A., & Calabrò, V. (2020) · Biochimie · doi:10.1016/j.biochi.2020.10.004 · Cited by 49
Zhang, W., Chen, Y. X., Li, M., Cao, S., Wang, N., Zhang, Y., & Wang, Y.-T. (2023) · Advanced Science · doi:10.1002/advs.202302855 · Cited by 33
Kohno, K., Wang, K., Takahashi, M., Kurita, T., Yoshida, Y., Hirakawa, M., Harada, Y., Kuma, A., Izumi, H., & Matsumoto, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819836 · Cited by 31
Self-citation
Metadata
- Authors
- Wu, Y., Wang, K.-Y., Li, Z., Liu, Y.-P., Izumi, H., Uramoto, H., Nakayama, Y., Ito, K.-I., & Kohno, K.
- Affiliations
- University of Occupational and Environmental Health Japan (JP)
- First Hospital of China Medical University (CN)
- Shinshu University (JP)
- Corresponding author
- Kohno, Kimitoshi
- Venue
- Journal of Experimental & Clinical Cancer Research
- Published
- 2014-12
- Volume
- 33
- Issue
- 1
- Pages
- 112-112
- ISSN
- 0392-9078 (ISSN-L)
- 1756-9966
- PMC
- PMC4308875
- OpenAlex
- W2153817817
- Cited by
- 17
- References
- 59
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 3 · 2021: 1 · 2020: 4 · 2019: 1 · 2017: 2 · 2016: 1 · 2015: 1
- FWCI
- 0.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Experimental & Clinical Cancer Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81201801)
- Japan Society for the Promotion of Science (24501323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- YB-1, camptothecin, drug sensitivity, protein-protein interaction, N-acetylcysteine, doxorubicin, topoisomerase II, DNA relaxation, chemoresistance, antioxidants
- MeSH terms
- Acetylcysteine, Antioxidants, Binding Sites, Camptothecin, Catalysis, DNA Topoisomerases, Type I, Enzyme Activation, Humans, Nucleic Acid Conformation, Protein Binding, Transfection, Down-Regulation, Gene Expression Regulation, Neoplastic, Oxidative Stress, Drug Resistance, Neoplasm, RNA Interference, Cell Line, Tumor, Y-Box-Binding Protein 1, Protein Interaction Domains and Motifs, Topoisomerase I Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction. https://app.cochat.ai/papers/10.1186/s13046-014-0112-7
- The paper
- Wu, Y., Wang, K.-Y., Li, Z., Liu, Y.-P., Izumi, H., Uramoto, H., Nakayama, Y., Ito, K.-I., & Kohno, K. (2014). Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-014-0112-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.